Demographic or Clinical Characteristic | Number of Patients (n = 61) | Percentage (%) |
---|---|---|
Gender | ||
 Male | 34 | 56 |
 Female | 27 | 44 |
Age, years | ||
  ≤ 59 | 44 | 72 |
  > 59 | 17 | 28 |
ECOG PS | ||
 0 | 17 | 28 |
 1 | 44 | 72 |
Primary tumor site | ||
 Stomach | 47 | 77 |
 Gastroesophageal junction | 14 | 23 |
Prior surgery of primary tumor | ||
 Yes | 40 | 66 |
 No | 21 | 34 |
Sites of metastatic disease | ||
 Abdominal lymph node | 34 | 56 |
 Liver | 27 | 44 |
 Primary | 14 | 23 |
 Lung | 11 | 18 |
 Ovarian | 10 | 16 |
 Distant lymph node | 10 | 16 |
 Peritoneum | 9 | 15 |
 Others | 11 | 18 |
First-line chemotherapy | ||
 5-FU/capecitabine + oxaliplatin | 13 | 21 |
 ECF/EOF/EOX | 34 | 56 |
 5-FU plus TXT/PTX | 13 | 21 |
 Capecitabine | 1 | 2 |